Filing search / Material / Tenax Therapeutics, Inc. / Page 4

424B3

EX-10.3

p92sm

24 Mar 14

Prospectus supplement

12:00am

424B3

EX-10.2

gjwfwn2th8 r6f2t

26 Nov 13

Prospectus supplement

12:00am

424B3

EX-10.1

wfhlbk82kohuefka 3m

26 Nov 13

Prospectus supplement

12:00am

8-K

EX-10.1

qz9fnb2

19 Nov 13

Oxygen Biotherapeutics Closes the Acquisition of

12:00am

8-K

EX-10.2

plbsjsuwaweojxfumb4

19 Nov 13

Oxygen Biotherapeutics Closes the Acquisition of

12:00am

424B3

EX-10.3

e7gddovps28of

30 Aug 13

Prospectus supplement

12:00am

424B3

EX-10.2

s3b8hk2vo2z

30 Aug 13

Prospectus supplement

12:00am

424B3

EX-10.1

dx4okqk5v4f

30 Aug 13

Prospectus supplement

12:00am

8-K

EX-10.2

nkfvxrrv4

26 Aug 13

Entry into a Material Definitive Agreement

12:00am

8-K

EX-10.1

m86cjaf 66kv3gtesp7

26 Aug 13

Entry into a Material Definitive Agreement

12:00am

8-K

EX-10.3

ivay 98i16mvmkypg

26 Aug 13

Entry into a Material Definitive Agreement

12:00am

424B3

EX-10.2

wyraiy6z

14 Aug 13

Prospectus supplement

12:00am

424B3

EX-10.1

7anv 273j7xy

14 Aug 13

Prospectus supplement

12:00am

8-K

EX-10.1

qd2wmo

13 Aug 13

Entry into a Material Definitive Agreement

12:00am

8-K

EX-10.2

0gqghnuy ctb

13 Aug 13

Entry into a Material Definitive Agreement

12:00am

8-K

EX-10.2

eh2awx

25 Jul 13

Oxygen Biotherapeutics Prices Public Offering

12:00am

8-K

EX-10.1

z1g8mr889t i95rm3np

25 Jul 13

Oxygen Biotherapeutics Prices Public Offering

12:00am

424B3

EX-10.2

w9tr19 kaj

25 Jul 13

Prospectus supplement

12:00am